Veracyte VCYT
NASDAQ VCYT
$45.78 +0.99 (+2.21%)
As of: Oct 21, 2026 · 1:05 PM EDT

Veracyte (VCYT) EV to EBIT (2024 - 2026)

Updated

Veracyte's (VCYT) EV to EBIT came in at 41.79 for Q2 2026, down 69.7% from 137.77 a year earlier but up 40.4% from the prior quarter.

Analysis

Veracyte (VCYT) EV to EBIT (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EV to EBIT at Veracyte was 32.89, down 62.3% year-over-year; for FY2025, it was 51.55, down 70.7% from FY2024.

  • In prior years, Veracyte's EV to EBIT was 175.98 in FY2024.
  • Quarterly EV to EBIT has run from a low of 29.76 in Q1 2026 to a high of 175.98 in Q4 2024 over five years.
  • On a year-over-year basis, EV to EBIT has declined in each of the last three quarters.
  • According to Business Quant data, EV to EBIT for the three prior quarters was 29.76 (Q1 2026), 51.55 (Q4 2025) and 96.85 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 102.03 Bn 98.04 Bn -
2 Natera 59.79 Bn 55.47 Bn 485.19 Mn
3 Quest Diagnostics 26.40 Bn 24.52 Bn 1.03 Bn
4 Labcorp Holdings 26.33 Bn 24.07 Bn 1.11 Bn
5 Tenet Healthcare 22.62 Bn 11.63 Bn -
6 Guardant Health 22.55 Bn 18.61 Bn 219.03 Mn
7 BrightSpring Health Services 12.97 Bn 11.30 Bn 492.75 Mn
8 Fresenius Medical Care AG 12.58 Bn 4.53 Bn 1.52 Bn
9 Tempus AI 12.19 Bn 9.22 Bn 246.50 Mn
10 Veracyte 3.66 Bn 2.42 Bn 108.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.79
Mar 31, 2026 29.76
Dec 31, 2025 51.55
Sep 30, 2025 96.85
Jun 30, 2025 137.77
Mar 31, 2025 90.10
Dec 31, 2024 175.98
API Access

Veracyte EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=VCYT&period=max&api_key=YOUR_API_KEY